Come up with a name for your new list and we'll add to it:
Cavion raised a round of funding on August 29, 2014. Investors include
CIT GAP Funds.
Cavion is a privately held clinical stage biotechnology company creating therapies modulating the T-type calcium channel (Cav3) for the treatment of neurological and oncologic diseases. Cavion is co-s…